* Imunon Inc IMNN.OQ IMNN.O is expected to show no
change in
quarterly revenue when it reports results on May 13 for the
period ending March 31 2024
*
* LSEG's mean analyst estimate for Imunon Inc is for a loss
of 57
cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 28.7%
in the last three months.
* Wall Street's median 12-month price target for Imunon Inc
is
$13.00, above its last closing price of $1.31.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.41 -0.52 Missed -26.8
Sep. 30 2023 -0.66 -0.66 -0.37 Beat 43.9
Jun. 30 2023 -0.70 -0.70 -0.61 Beat 13.5
Mar. 31 2023 -0.66 -0.66 -0.68 Missed -2.5
Dec. -0.85 -1.61 Missed -89.4
31 2022
Sep. 30 2022 -0.79 -0.81 -0.87 Missed -7.4
Jun. 30 2022 -1.44 -1.12 -0.87 Beat 22.5
Mar. 31 2022 -0.99 -0.99 -1.82 Missed -83.8
This summary was machine generated May 7 at 16:55 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)